- Report
- December 2024
- 175 Pages
Global
From €4775EUR$5,000USD£3,993GBP
- Clinical Trials
- April 2024
- 40 Pages
Global
From €1194EUR$1,250USD£998GBP
- Report
- March 2025
- 200 Pages
Global
From €4288EUR$4,490USD£3,586GBP
- Report
- May 2024
- 128 Pages
Global
From €6207EUR$6,499USD£5,190GBP
- Report
- June 2024
- 200 Pages
Global
From €7593EUR$7,950USD£6,349GBP
- Report
- January 2022
- 200 Pages
Global
From €7163EUR$7,500USD£5,990GBP
- Report
- January 2022
- 60 Pages
Global
From €3772EUR$3,950USD£3,155GBP
- Report
- August 2023
- 159 Pages
Global
From €2388EUR$2,500USD£1,997GBP
- Report
- February 2023
- 219 Pages
Global
From €3438EUR$3,600USD£2,875GBP
- Report
- February 2023
- 90 Pages
Middle East, Africa
From €1433EUR$1,500USD£1,198GBP
- Report
- February 2023
- 90 Pages
Asia Pacific
From €1433EUR$1,500USD£1,198GBP
- Report
- February 2023
- 90 Pages
Europe
From €1433EUR$1,500USD£1,198GBP
- Report
- February 2023
- 80 Pages
North America
From €1433EUR$1,500USD£1,198GBP
- Report
- May 2022
- 37 Pages
Global
From €1910EUR$2,000USD£1,597GBP
- Report
- January 2023
- 241 Pages
Global
From €3409EUR$3,570USD£2,851GBP

Sciatica is a condition that affects the sciatic nerve, which runs from the lower back down the legs. It is characterized by pain, numbness, and tingling in the lower back, buttocks, and legs. Treatment for sciatica typically involves medications, physical therapy, and lifestyle changes.
Central nervous system (CNS) drugs are used to treat a variety of conditions, including sciatica. These drugs work by targeting the brain and spinal cord to reduce pain and inflammation. Common CNS drugs used to treat sciatica include non-steroidal anti-inflammatory drugs (NSAIDs), muscle relaxants, and opioids.
The sciatica drug market is a subset of the CNS drug market. It is composed of pharmaceutical companies that specialize in developing and manufacturing drugs to treat sciatica. These companies are typically involved in research and development, clinical trials, and marketing of their products.
Some companies in the sciatica drug market include Pfizer, GlaxoSmithKline, Merck, and Novartis. Show Less Read more